Andreas K.
- Country
- Germany
- Department
- Studienzentrum Viszeralonkologie
Research Overview
- Comparison of Neoadjuvant Radiochemotherapy Versus Chemotherapy in Locally Advanced Resectable Gastroesophageal Junction Adenocarcinoma Using Fluorouracil, Docetaxel, Oxaliplatin, and Calcium Folinate
- Phase III Trial of Perioperative FLOT with HIPEC Versus FLOT Alone in Resectable Diffuse Gastric and Gastroesophageal Junction Adenocarcinoma
Data & Insights
Has run more than one trial at 8 of 51 partner sites.
Specializations
Gastrointestinal Oncology
This investigator specializes in treating adenocarcinomas of the gastroesophageal junction (GEJ), with particular expertise in both localized and advanced disease states.
- GEJ Type I-III Adenocarcinomas
- Diffuse Type Gastric Cancer
- Resectable GEJ Malignancies
Their work encompasses innovative treatment approaches for upper gastrointestinal tract cancers.
Therapeutic Approaches
The investigator focuses on developing comprehensive treatment strategies incorporating multimodal therapy for gastrointestinal cancers.
- Neoadjuvant Radiochemotherapy
- Perioperative Chemotherapy
- Surgical Interventions
Their expertise includes evaluating various treatment sequences to optimize patient outcomes.
Surgical Oncology
The investigator has significant experience in oncologic surgical procedures for gastrointestinal malignancies.
- D2 Resection Techniques
- Mediastinal Lymphadenectomy
- Resectable Tumor Management
Their surgical approach integrates with comprehensive cancer treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.